Sun Pharmaceutical Industries Ltd.’s quarterly profit jumped twofold as a surge in other income offset the drop in sales at the U.S. subsidiary.
Show more
Shares of Sun Pharma gained as much as 6.3% - the most in nine months to Rs 600, post the announcement. The stock had underperformed the benchmark Nifty 50 during the October-December period as it gained 18.3% compared with the 24.3% surge in the benchmark.
WRITTEN BY
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT